Compulsory Licences and its Importance Worldwide in Patents Regime

HEPATITIS C – VACCINE AND PATENT Gilead Sciences’ sofosbuvir, a drug for Hepatitis C was approved in 2013 by US Food & Drug Administration was immediately criticized for its high cost as its price is so elevated relative to production cost.23 The average cost of a 12-week treatment of sofosbuvir is $84,000 per patient, despite […]